Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

FDA Report Says Pfizer Chinese Plant Hid Failures, Used Expired Ingredients

NEW YORK – A Chinese drug manufacturing facility run by Pfizer Inc. (PFE) is under scrutiny by the U.S. Food and Drug Administration (FDA) after regulators discovered the use of expired materials and a second set of quality and manufacturing records that did not match official documentation, Bloomberg reported this morning.   However, Pfizer said […]

Read More »

PDI Enters Definitive Agreement to Sell Its Commercial Services Business to Publicis Healthcare Communications Group

PDI to Focus on Growing Molecular Diagnostics Business; Plans to Change Name to Interpace Diagnostics Group PDI to receive $25.5 to $32.5 million up front cash payment and a contingent earnout payment Combination Would Create A Global Leader in Healthcare Commercial Services   PARSIPPANY, N.J. & YARDLEY, Pa., Nov. 2, 2015 /PRNewswire/ — PDI, Inc. (Nasdaq: […]

Read More »

Drugged up: GSK, Roche and Sanofi to set out their stalls

Three of Europe’s top drugmakers – GlaxoSmithKline, Roche and Sanofi – face health checks this week at high-profile presentations designed to show they can overcome looming market threats. The unusual confluence of investor days comes at a testing time for the $1 trillion-a-year global drugs industry, as deal-making sweeps a sector facing mounting competitive pressures. […]

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

October 2018 Focus: Top 50 Pharma, Company of the Year and more!


Ad Right Bottom